Christophe Abi Zeid Daou, MD
Fellow
Pediatric Otolaryngology
Abdullah AlDaihani, MD, B. Med. SC
Clinical Instructor
Laryngology
Jacquelyn Callander, MD
Clinical Instructor
Rhinology
Catherine (Po Ling) Chan, MBChB
Clinical Instructor
Head & Neck Surgery
Tatiana Correa, MD, MPH
Clinical Instructor
Facial Plastic & Reconstructive Surgery
Perla Villamor, MD
Clinical Instructor
Pediatric Otolaryngology
Thomas Young, MBBS, DDS,
Clinical Instructor
Sleep Surgery
Emily Zhang, MD
Clinical Instructor
Head & Neck Surgery
2025 Clinical Instructors and Fellow Bios
Our LPCH team, led by Stanford Children’s Surgeon-in-Chief Karthik Balakrishnan, MD, MPH, Professor of Otolaryngology — Head & Neck Surgery, has received FDA approval to conduct a major study to advance robotic surgical care in children.
The team has developed a novel robotic tracheal reconstruction technique and features several other department faculty in key roles, including Chris Holsinger, MD, Doug Sidell, MD, Kara Meister, MD, and Alyssa Smith, MD. The group, along with surgeons from multiple other specialties, will be investigating the safety of robotic procedures for nine different pediatric and adolescent indications in the first phase of the study. We expect this landmark study to dramatically broaden the scope of robotic surgery in children and teens, with future phases of the work to include development of new robotic operations and new indications.
The American Otological Society established the Award of Merit in 1948 to recognize outstanding accomplishments and distinguished service in the field of otology. Created amid concerns that otology was becoming a “dying specialty” due to medical advances like antibiotics, the award celebrated those driving innovation in surgery, research, and education. Early recipients, including Nobel laureate Georg von Békésy, made groundbreaking contributions to auditory physiology and temporal bone pathology. Over the decades, the Award has remained the Society’s highest honor, recognizing leaders who have shaped the field.
Chris Holsinger, MD has been selected as the Surgery Chair of the NRG Oncology’s Head and Neck Cancer Committee.
The NRG Oncology Head and Neck Cancer Committee’s purpose is to improve the lives of head and neck cancer patients by designing and conducting practice-changing multi-institutional clinical trials and translational research. The Committee supervises numerous Working Groups which act to identify novel scientific advances that are incorporated into our trials, support conduct and completion of our clinical trials and other research activities, and promote further learning and dissemination from our research findings.
For the past 15 years, Zara M. Patel, MD has been investigating the underlying causes of smell loss and treating patients experiencing this condition. Recent evidence shows that smell loss may be the first sign of diseases such as Parkinson’s and Alzheimer’s – and that degeneration may begin in the olfactory cortex—making research in this area even more important and urgent! Visit our website to to learn more!
Kristen Steenerson, MD has been selected to participate in an exclusive session titled “Game Changers” at the AAO-HNSF 2025 Annual Meeting & OTO EXPO.
This inaugural session celebrates landmark articles that have significantly transformed otolaryngology practice. Dr. Steenerson's article, "Clinical Practice Guideline: Age-Related Hearing Loss," published in Otolaryngology–Head and Neck Surgery, was personally chosen by Editor-in-Chief Cecelia E. Schmalbach, MD, MSc, for its profound impact on the field. During the session, Dr. Steenerson will present her findings and discuss the transformative effects of her research on patient care. This opportunity highlights the importance of innovative research in advancing otolaryngology and recognizes the contributions that have reshaped clinical practice.
Dr. Andrey Finegersh has received an R03 grant from NIH for his project "ACTL6a ties metabolic reprogramming to cancer stem cell maintenance in oral cavity squamous cell carcinoma."
Head and neck cancer is the sixth most common cancer worldwide and outcomes remain poor for many patients, with limited treatment gains over the last several decades. Changes in cancer metabolism are common in head and neck cancer but are not exploited for treatment benefit. This proposal studies a gene called ACTL6A to show how it regulates metabolism of head and neck cancers with the goal of developing new treatments.
Dr. Fred Baik has received funding from VLP Therapeutics LLC for his project “Study of Intratumoral Injections of VLPONC-01 in Head and Neck Cancer.” The objective of this study is to determine whether the study medication called VLPONC-01 is safe and effective, and whether it has any beneficial effect on the immune response to the tumor. VLPONC-01 has been shown to be effective in treating head and neck cancers in animal models.
Dr. Michelle Chen was awarded an AHNS Pilot Grant by the American Academy of Otolaryngology – Head & Neck Surgery Foundation (AAO-HNSF) and the Centralized Otolaryngology Research Effort (CORE) Study Section for her proposal, “Development of a Food is Medicine Intervention for Head and Neck Cancer.” This project seeks to develop a Food is Medicine intervention to address the nutritional challenges of head and neck cancer (HNC) patients during treatment and survivorship. Successful completion of this project will inform the developed of a future pilot study utilizing this intervention and then creating a larger multi-institutional study on deploying a Food is Medicine intervention at Stanford, UC Davis, and Santa Clara Valley Healthcare.
Dr. Grace Kim was awarded an ASPO Research Grant by the American Academy of Otolaryngology – Head & Neck Surgery Foundation (AAO-HNSF) and the Centralized Otolaryngology Research Effort (CORE) Study Section for her proposal, “Role of Cochlear Immune Cells in Congenital Cytomegalovirus-Related Hearing Loss.”
Congenital cytomegalovirus (cCMV) infection is recognized as the most common non-genetic cause of sensorineural hearing loss in children, yet the pathogenesis of this hearing loss remains poorly understood. This study will utilize a mouse model of congenital CMV infection to examine long-term dysfunction of natural killer cells and its role in delayed onset hearing loss, thereby identifying potential biomarkers for improved diagnosis and disease monitoring.
Cort Breuer was awarded an NCI Ruth L. Kirschstein NRSA for Individual Predoctoral Fellows (F31) Award.
Immunology PhD Student, Cort Breuer, was awarded an F31 Award for his proposal, developed under the mentorship of Dr. Nathan Reticker-Flynn, “Investigating evolutionary antagonism between tumors and lymphocytes.” The goal of this proposal is to investigate the relationship between clonotypic and phenotypic diversity between tumors and lymphocytes in the context of cancer metastasis. The results have the potential to provide an integrative model of tumor evolution and immune dysfunction during metastasis, and to inform the development of therapies that target these evasion mechanisms, such as by enhancing the diversity of the lymphocyte compartment to overcome limited diversity.
Resident Maxwell Lee was awarded an AHNS Alando J. Ballantyne Resident Research Pilot Granby the American Academy of Otolaryngology – Head & Neck Surgery Foundation (AAO-HNSF) and the Centralized Otolaryngology Research Effort (CORE) Study Section for his proposal, “Spatial Transcriptomic Analysis of Cutaneous Squamous Cell Carcinoma.” This study will investigate the spatial transcriptomic landscape of cSCC, particularly focusing on tumor-specific keratinocytes (TSK) and their interactions with the immune microenvironment in response to immunotherapy. The overarching objective is to uncover actionable insights that could inform treatment strategies and improve patient outcomes in advanced cSCC.
Resident Shannon Wu was awarded an AAO-HNSF Resident Research Grant by the American Academy of Otolaryngology – Head & Neck Surgery Foundation (AAO-HNSF) and the Centralized Otolaryngology Research Effort (CORE) Study Section for her proposal, developed under the mentorship of Dr. Michelle Chen, “Developing a Financial Hardship Patient-Reported Outcome in Head and Neck Cancer.” Cancer-related medical costs are projected to increase by 34% from 2015 to 2030, leading to significant financial hardship for patients, particularly those with head and neck cancer (HNC), which has higher costs and unique challenges; thus, this study aims to develop a HNC-specific measure of financial hardship, called COST-HNC, to better assess and address the financial burdens faced by these patients.